Daniel S. Goldberger
Chairman of the Board, Interim CEO
Director and Chairman since 2018
Mr. Goldberger was appointed as Chairman of the Board of Directors and interim Chief Executive Officer on July 25, 2018, replacing Mr. Andrew Sealfon. Mr. Goldberger has over 35 years of experience within the biotech, medical technology, and high tech industries. His areas of expertise include mergers and acquisitions, capital formation, intellectual property, product development, supply chain, business analytics, and turnarounds. Since January 2018, Mr. Goldberger is the Chief Executive Officer of Synergy Disc Replacement Inc., a private company commercializing a proprietary total disc implant for cervical spine therapy. Mr. Goldberger served as Chief Executive Officer of Milestone Medical, Inc. until October 2017. Prior to this, he served as the Chief Executive Officer of Xtant Medical Holdings, Inc. from August 2013 to January 2017. He also served as the Chief Executive Officer of Sound Surgical Technologies LLC from April 2007 to February 2013. Mr. Goldberger served on the boards of Xtant Medical Holdings, Inc., Sound Surgical, Xcorporeal and Glucon. He currently serves as an advisor to investment funds with Meridian Capital and Wellfleet Capital. Mr. Goldberger earned his B.S. in Mechanical Engineering from M.I.T, his M.S. in Mechanical Engineering from Stanford University and attended the Stanford Directors College.
Donald B. Pettigrew
President and Chief Commercial Officer
Mr. Pettigrew has more than 23 years of sales and business development experience in the medical device industry, including the home infusion space. He has held senior leadership positions at market leading medical firms such as Moog, Inc., Baxter (formerly Gambro) and Boston Scientific. At Moog, he held senior roles from 2011 to 2018 as Group Director, Global Business Development and Group Director, Global Sales and Professional Services where he led commercialization and business development for the IV infusion and enteral feeding franchises in both the U.S. and international markets. While at Moog, he helped the medical division grow sales and profitability to well over one hundred million dollars. Mr. Pettigrew holds a BA in Biology from the University of Colorado, Boulder.
Dr. Fred Ma
Chief Medical Officer
Dr. Fred Ma brings over 30 years of broad experience based on his neurosurgical practice, with significant emphasis in pharmaceuticals and medical device industries. Dr. Ma has a successful track record in all phases of product research and development culminating in final approvals, clearances, and commercialization. He is prominent within regulatory agencies and a multitude of professional organizations. Dr. Ma has directly designed and supervised numerous product developments, 600 clinical trials and many successful regulatory approvals and clearances worldwide. He ushers in significant business growth with noteworthy achievement in bringing new products to market with agile skill. Dr. Ma earned his M.D. degree from Capital University of Medical Sciences, Beijing, D.M.Sc. (Doctorate of Medical Sciences (equivalent to combined M.D. and Ph.D. degrees) from Tokyo University, Japan, and a Ph.D. from Rutgers University.
Chief Financial Officer
Karen Fisher has more than 25 years of financial experience in a variety of industries, most recently serving as the Assistant Controller for a global consumer products company. She has also held roles such as Chief Accounting Officer and Treasurer, and Controller. Ms. Fisher held multiple financial management roles covering financial analysis and reporting, budgeting, forecasting, acquisitions, and cash management. She is thoroughly knowledgeable in compliance with SEC regulation, GAAP, 10Q’s, 10K’s and Sarbanes-Oxley. Ms. Fisher is a Certified Public Accountant and a graduate of Arizona State University with a BS in Accounting.
Chief Operating Officer
Manny Marques has an engineering background in FDA Class II & III medical devices. He has a proven history of effectively transferring new products from R&D into manufacturing, while also reducing operating and manufacturing costs of existing products. Mr. Marques is a champion at enhancing operational management via implementation of Lean 6-Sigma Manufacturing techniques. Mr. Marques holds two U.S. patents for cardiovascular medical devices. Manny obtained a BS in Mechanical Engineering Technology and also an MS in Engineering Management from the New Jersey Institute of Technology.